Q2 2026 13F · SEC CIK 1442891

Eventide Asset Management, LLC

Mutual fund managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $7.5B
Reported positions: 301
Top holdings a year, 3 yrs: +19.1%
Assets under management: $7.4B

Eventide Asset Management, LLC is a mutual fund manager that reported 301 positions worth $7.5B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Guardant Health Inc (GH, 3.9%), Lam Research Corp (LRCX, 3.9%), Xometry, Inc. (XMTR, 2.8%). A portfolio copying its top holdings returned 19.1% a year over the last 3 years, against 20.4% for the S&P 500.

Eventide Asset Management, LLC holdings largest 50 of 301 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Eventide Asset Management, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
GHGuardant Health Inc	3.9%	3.6%	1,957,828	-17.1%	$293.8M
LRCXLam Research Corp	3.9%	2.4%	673,431	-2.2%	$291.7M
XMTRXometry, Inc.	2.8%	2.0%	2,151,845	-27.3%	$208.4M
TTTrane Technologies PLC	2.7%	2.8%	415,039	+2.1%	$203.5M
MIRMMirum Pharmaceuticals Inc	2.0%	2.2%	1,248,389	-11.4%	$146.2M
ASMLAsml Hldg NV	1.8%	1.5%	68,410	+0.4%	$136.0M
TRGPTarga Res Corp	1.8%	2.1%	490,719	-2.3%	$131.7M
ODFLOld Dominion Freight Line in	1.7%	1.9%	599,458	+1.3%	$129.9M
GEVGe Vernova Inc	1.7%	1.9%	106,999	-19.7%	$124.7M
URIUnited Rentals Inc	1.6%	1.2%	103,445	+5.8%	$117.2M
ARGNFArgenx SE	1.6%	1.5%	125,668	+0.0%	$116.6M
SRRKScholar Rock Hldg Corp	1.6%	1.8%	2,111,410	-3.9%	$116.1M
IRTCIrhythm Technologies Inc	1.4%	1.5%	880,338	+15.7%	$104.7M
KLACKla Corp	1.3%	1.0%	339,253	+755.9%	$100.9M
BBNXBeta Bionics Inc	1.3%	1.0%	6,253,673	+5.2%	$98.1M
LSCCLattice Semiconductor Corp	1.2%	0.9%	611,272	+0.0%	$93.5M
NVTNvent Elec PLC	1.2%	1.0%	536,108	+2.4%	$90.6M
GNRCGenerac Hldgs Inc	1.2%	1.0%	306,850	+0.0%	$89.8M
DDOGDatadog Inc	1.2%	—	342,324	—	$89.0M
PANWPalo Alto Networks Inc	1.1%	0.7%	251,535	-0.2%	$85.7M
ETREntergy Corp New	1.1%	1.3%	728,019	+6.6%	$83.9M
PCVXVaxcyte Inc	1.1%	1.3%	1,380,219	+0.4%	$80.2M
MPWRMonolithic Pwr Sys Inc	1.1%	1.0%	57,790	-0.6%	$79.7M
VSTVistra Corp	1.1%	1.2%	499,466	+1.4%	$79.4M
DELLDell Technologies Inc	1.1%	—	185,502	—	$79.3M
RPRXRoyalty Pharma PLC	1.0%	1.0%	1,380,261	+5.2%	$77.7M
AXSMAxsome Therapeutics, Inc.	1.0%	1.5%	316,820	-39.0%	$77.5M
TERTeradyne Inc	1.0%	—	147,984	—	$71.4M
DHID R Horton Inc	1.0%	1.0%	436,562	+1.3%	$71.1M
TOSTToast Inc	0.9%	1.1%	2,494,706	+0.2%	$69.4M
PWRQuanta Svcs Inc	0.9%	0.8%	93,231	+4.3%	$67.1M
WMBWilliams Cos	0.9%	1.0%	898,241	+7.9%	$66.9M
MTDMettler Toledo International	0.9%	1.1%	52,116	+2.7%	$66.5M
INSMInsmed Inc	0.8%	1.5%	583,665	+6.8%	$62.2M
RBARb Global Inc	0.8%	0.8%	528,645	+0.1%	$61.5M
LBRTLiberty Energy Inc	0.8%	1.1%	2,314,729	-3.7%	$60.6M
BLTEBelite Bio Inc	0.8%	0.9%	390,829	+9.3%	$60.2M
DTMDt Midstream Inc	0.8%	0.9%	407,626	+1.4%	$59.8M
KYMRKymera Therapeutics Inc	0.8%	0.9%	504,210	-19.6%	$57.8M
NDAQNasdaq Inc	0.7%	1.0%	711,213	-0.1%	$55.9M
SITMSitime Corp	0.7%	—	74,014	—	$55.1M
NINiSource Inc	0.7%	0.9%	1,158,290	+1.3%	$55.1M
ESIElement Solutions Inc	0.7%	—	1,149,055	—	$54.7M
NVDANvidia Corporation	0.7%	0.7%	273,735	+5.5%	$54.4M
ABVXAbivax SA	0.7%	—	394,957	—	$52.6M
VMCVulcan Matls Co	0.7%	0.8%	169,825	+0.1%	$50.1M
ORLYOreilly Automotive Inc	0.7%	0.8%	544,082	+0.8%	$50.0M
TRVITrevi Therapeutics Inc	0.7%	—	2,660,000	—	$49.6M
COLLCollegium Pharmaceutical Inc	0.7%	0.8%	1,361,228	-4.4%	$49.3M
EGPEastgroup Pptys Inc	0.7%	0.7%	241,049	+2.3%	$48.9M

What Eventide Asset Management, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

KLAC Kla Corp+755.9% shares
IRTC Irhythm Technologies Inc+15.7% shares
BLTE Belite Bio Inc+9.3% shares
WMB Williams Cos+7.9% shares
INSM Insmed Inc+6.8% shares
ETR Entergy Corp New+6.6% shares
URI United Rentals Inc+5.8% shares
NVDA Nvidia Corporation+5.5% shares

Reduced

AXSM Axsome Therapeutics, Inc.-39.0% shares
XMTR Xometry, Inc.-27.3% shares
GEV Ge Vernova Inc-19.7% shares
KYMR Kymera Therapeutics Inc-19.6% shares
GH Guardant Health Inc-17.1% shares
MIRM Mirum Pharmaceuticals Inc-11.4% shares

Left the top 50

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +46.0% /yr; S&P 500 +20.1%
3 years: +19.1% /yr; S&P 500 +20.4%
5 years: +6.4% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$7.5B	301
Q1 2026	$6.0B	278
Q4 2025	$6.4B	268
Q3 2025	$6.1B	239
Q2 2025	$5.7B	237
Q1 2025	$5.0B	217
Q4 2024	$5.5B	204
Q3 2024	$5.8B	180
Q2 2024	$5.8B	159
Q1 2024	$6.4B	156
Q4 2023	$6.1B	151
Q3 2023	$5.6B	154

Questions about Eventide Asset Management, LLC's portfolio

What stocks does Eventide Asset Management, LLC own?

Eventide Asset Management, LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 301 positions worth $7.5B. The largest are Guardant Health Inc (GH) at 3.9%, Lam Research Corp (LRCX) at 3.9%, Xometry, Inc. (XMTR) at 2.8%, Trane Technologies PLC (TT) at 2.7% and Mirum Pharmaceuticals Inc (MIRM) at 2.0%.

What did Eventide Asset Management, LLC buy last quarter?

In Q2 2026, Eventide Asset Management, LLC added Kla Corp (KLAC) (+755.9% shares), Irhythm Technologies Inc (IRTC) (+15.7% shares) and Belite Bio Inc (BLTE) (+9.3% shares), compared with its Q1 2026 filing.

What did Eventide Asset Management, LLC sell last quarter?

In Q2 2026, Eventide Asset Management, LLC cut from its top 50 Prologis Inc (PLD), cut from its top 50 Transmedics Group Inc (TMDX), cut from its top 50 Waste Connections Inc (WCN), cut from its top 50 Apogee Therapeutics Inc (APGE), cut from its top 50 Ionis Pharmaceuticals Inc (IONS), Axsome Therapeutics, Inc. (AXSM) (-39.0% shares), Xometry, Inc. (XMTR) (-27.3% shares) and Ge Vernova Inc (GEV) (-19.7% shares), compared with its Q1 2026 filing.

How has Eventide Asset Management, LLC's portfolio performed?

A portfolio copying Eventide Asset Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +19.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +46.0% against +20.1%. Over 5 years: +6.4% a year against +11.6%.

When is Eventide Asset Management, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Eventide Asset Management, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Eventide Asset Management, LLC manage?

Eventide Asset Management, LLC reported $7.4B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $7.5B.